Pharmarise Holdings Corporation (TYO:2796)

Pharmarise Holdings Balance Sheet

Financials in millions JPY. Fiscal year is June - May.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 28, 2025	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021	May 31, 2020
Cash & Equivalents	2,243	7,150	4,742	3,991	4,604	4,472
Cash & Short-Term Investments	2,243	7,150	4,742	3,991	4,604	4,472
Cash Growth	-56.56%	50.78%	18.82%	-13.31%	2.95%	1.57%
Accounts Receivable	2,016	1,439	605	479	926	957
Other Receivables	2,808	2,117	3,412	3,786	2,159	2,366
Receivables	4,824	3,556	4,017	4,265	3,085	3,323
Inventory	4,462	2,645	2,290	2,302	2,587	2,644
Other Current Assets	414	386	323	320	270	237
Total Current Assets	11,943	13,737	11,372	10,878	10,546	10,676
Property, Plant & Equipment	7,331	6,198	6,010	6,355	6,434	6,332
Long-Term Investments	4,241	2,296	2,008	2,139	2,488	2,094
Goodwill	7,080	5,917	2,748	3,220	4,025	4,697
Other Intangible Assets	505	502	502	409	439	588
Long-Term Deferred Tax Assets	-	834	778	741	786	802
Long-Term Deferred Charges	-	-	-	1	2	4
Other Long-Term Assets	2	2	2	2	2	3
Total Assets	31,102	29,486	23,421	23,746	24,724	25,206
Accounts Payable	5,935	5,690	4,252	4,109	4,609	5,192
Accrued Expenses	306	903	805	708	699	557
Short-Term Debt	-	-	-	-	-	20
Current Portion of Long-Term Debt	2,522	2,655	3,490	2,276	2,565	2,809
Current Portion of Leases	-	176	187	214	254	267
Current Income Taxes Payable	137	286	333	429	573	324
Other Current Liabilities	1,487	978	768	741	692	867
Total Current Liabilities	10,387	10,688	9,835	8,477	9,392	10,036
Long-Term Debt	11,725	9,654	5,216	7,085	7,432	7,546
Long-Term Leases	-	264	245	337	446	587
Other Long-Term Liabilities	944	499	349	368	416	417
Total Liabilities	24,107	22,046	16,436	17,048	18,394	19,262
Common Stock	1,961	1,961	1,298	1,274	1,251	1,229
Additional Paid-In Capital	2,186	2,177	1,553	1,529	1,476	1,437
Retained Earnings	3,033	3,530	4,014	3,811	3,494	3,197
Treasury Stock	-471	-550	-210	-210	-208	-172
Comprehensive Income & Other	236	242	225	203	207	216
Total Common Equity	6,945	7,360	6,880	6,607	6,220	5,907
Minority Interest	50	80	105	91	110	37
Shareholders' Equity	6,995	7,440	6,985	6,698	6,330	5,944
Total Liabilities & Equity	31,102	29,486	23,421	23,746	24,724	25,206
Total Debt	14,247	12,749	9,138	9,912	10,697	11,229
Net Cash (Debt)	-12,004	-5,599	-4,396	-5,921	-6,093	-6,757
Net Cash Per Share	-1062.93	-532.02	-352.52	-477.64	-492.49	-540.54
Filing Date Shares Outstanding	11.36	11.24	9.43	9.35	9.29	9.28
Total Common Shares Outstanding	11.36	11.24	9.43	9.35	9.3	9.29
Working Capital	1,556	3,049	1,537	2,401	1,154	640
Book Value Per Share	611.31	654.62	729.93	706.43	668.98	635.77
Tangible Book Value	-640	941	3,630	2,978	1,756	622
Tangible Book Value Per Share	-56.33	83.69	385.12	318.41	188.86	66.95

Updated Jan 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.